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Abstract: The aim of the present study was undertaken to evaluate the effects of a Consciousness Energy Healing (The 
Trivedi Effect
®
) Treatment based test formulation on skin health. The test formulation and DMEM were separated into two 
parts. One part of each received the Consciousness Energy Healing Treatment by Shirley Theresa Holmlund
 
and were termed 
as the Biofield Energy Treated samples, while the other parts were considered as the untreated test samples. MTT assay 
showed more than 70% cells were viable in all the tested concentrations in three cell lines and that the test formulation was 
safe and nontoxic. The percent cell proliferation using BrdU assay was significantly increased by 343.57%, 100.29%, and 
132.6% in the UT-DMEM + BT-Test formulation, BT-DMEM + UT-Test formulation, and BT-DMEM + BT-Test formulation 
groups, respectively at 8.75 µg/mL compared to the UT-DMEM + UT-Test formulation group. The collagen synthesis was 
significantly increased by 5.94% and 10.84% in the UT-DMEM + BT-Test formulation and BT-DMEM + BT-Test formulation 
groups, respectively at 0.625 µg/mL with respect to the untreated group. Elastin level was significantly (p≤0.001) increased by 
15.95%, 58.31%, and 47.18% at 2.5 µg/mL in the UT-DMEM + BT-Test formulation, BT-DMEM + UT-Test formulation, and 
BT-DMEM + BT-Test formulation groups, respectively compared to the untreated group. The level of hyaluronic acid was 
significantly increased by 15.13% and 68.56% in the BT-DMEM + UT-Test formulation and BT-DMEM + BT-Test 
formulation groups, respectively at 0.625 µg/mL compared to the untreated group. The level of melanin was significantly 
reduced by 17.06%, 6.94%, and 13.07% in the UT-DMEM + BT-Test formulation, BT-DMEM + UT-Test formulation, and 
BT-DMEM + BT-Test formulation groups, respectively at 0.063 µg/mL compared to untreated group. The effect of skin 
protection upon exposure with UV-B rays displayed some alteration of the percent cell viability in all the tested groups. The 
wound healing activity by scratch assay exhibited significant wound closure and cell migration in the test formulation and 
DMEM in HFF-1 cells compared to the untreated group. Altogether, the data suggests that the Consciousness Energy Healing 
Treated DMEM and test formulation exhibited better skin protective responses compared to the untreated DMEM and test 
formulation group with respect to the skin health parameters. Therefore, the Biofield Energy Treated test formulation could be 
developed as a potential cosmetic product against various skin problems viz. eczema, vitiligo, psoriasis, acne, hives, rosacea, 
ichthyosis, seborrheic dermatitis, erythema, contact dermatitis, skin aging, wrinkles, etc. 
Keywords: Consciousness Energy Healing, The Trivedi Effect®, Skin Protection, HFF-1; B16-F10, HaCaT, Wound Healing, 
Extracellular Matrix 
 
1. Introduction 
The use of herbal preparations has been cited with 
excellent outcomes for skin health. The herbomineral based 
formulations are considered as a well-being combination of 
herbs and minerals. The Herbal based products have been 
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used as holistic medicine for thousands of years, however the 
modern populations are dependent on various other forms 
like drugs, cosmetics, and agrochemicals [1]. These types of 
formulations also have been reported therapeutic benefits 
against different chronic diseases. Most of the cosmetic 
preparations used against skin darkening activity are based 
on the presence of phytoconstituents, which are derived from 
herbs [2], and their high demands are due to lower incidence 
of adverse effects compared with the synthetic compounds 
[3, 4]. Additionally, various types of products like photo-
aging, antioxidant (i.e. vitamin B3, C, and E), invasive 
measures (gene therapy and chemical peels) and several 
devices (laser energy, injectable, etc.) are used for skin health 
and rejuvenation [5, 6]. Based on the retrieved scientific 
literature, the proprietary herbomineral formulation consists 
of essential minerals (zinc chloride, sodium selenate, and 
sodium molybdate), vitamin (L-ascorbic acid), 
tetrahydrocurcumin (THC), and herbal extract (Centella 
asiatica). Each ingredient already has been proven for its 
potential activity on skin health as evidenced through use in 
various medicines as well as cosmeceuticals. Zinc is an 
essential cofactor of various metalloenzymes and it protects 
the skin from UV irradiation and has been used as a 
destructive agent for the management of cancer [7, 8]. 
Sodium selenate enhances the repair system of DNA 
segments and reduces the risk of new cancer development [9, 
10]. Numerous literature suggests that it prevents skin 
cancers in combination with L-selenomethionine [11, 12]. 
Molybdenum is also an essential element for humans, 
animals, and plants and acts as a key constituent of various 
important enzymes [13, 14]. Ascorbic acid plays a vital role 
in repair of damaged skin and modulates collagen production 
[15]. THC exhibits antioxidant property and has been 
routinely used as a skin care formulation for the treatment of 
various skin related problems [16, 17]. The herbal extract of 
C. asiatica can enhance the process of wound healing and 
provides significant benefits in skin care products. Hashim et 
al. (2011) reported that C. asiatica leaves extract enhanced 
the synthesis of collagen and has the potential antioxidant, 
anti-cellulite, and UV protectant activities. It is also used in 
proprietary medicinal products for the treatment of cutaneous 
ulcer, hypertrophic scars, keloids, and wound healing 
disorders [18-20].  
The National Center for Complementary and Integrative 
Health (NCCIH), allows the use of Complementary and 
Alternative Medicine (CAM) therapies like Biofield Energy 
as an alternative treatment in the healthcare field. About 36% 
of US citizens are regularly using some form of CAM [21], 
in their daily life. CAM embraces numerous Energy Healing 
Therapies; Biofield Therapy is one of the energy medicines 
used worldwide to improve overall human health. 
Researchers have shown that short-lived electrical events or 
action potential exists in the several types of mammalian 
cells such as neurons, muscles, and endocrine cells [22]. For 
instance, when the cells present in central nervous system of 
human body communicate with each another by means of 
electrical signals that propagate along the nerve impulses. 
Therefore, it was hypothesized that Biofield exists around the 
human body and evidence was found using 
electromyography, electrocardiography and 
electroencephalogram [23]. Thus, a Biofield Energy Healing 
Practitioner has the ability to harness the energy from the 
environment and can transmit it into any object (living 
organism or non-living material) around the globe. The 
object(s) always receives the energy and respond it in a 
useful way that is called “Biofield Energy”. This process is 
known as “Biofield Energy Healing”. Biofield Energy 
Healing has been approved as an alternative method that has 
an impact on various properties of living organisms in a cost-
effective manner [24, 25]. The Trivedi Effect
®
 Unique 
Biofield Energy Healing Treatment has been known to alter 
the response in a wide-spectrum fields in living and non-
living systems viz. materials science [26-28], agriculture [29, 
30], microbiology [31-33] biotechnology [34, 35]. Based on 
the excellent outcome of the Biofield Energy Treatment, the 
authors designed this study to investigate the impact of the 
Biofield Energy Healing Treatment on DMEM and the test 
formulation with respect to various skin health parameters 
using three cell lines such as human foreskin fibroblast 
(HFF-1), human keratinocytes (HaCaT), and mouse 
melanoma (B16-F10) cell lines.  
2. Materials and Methods 
2.1. Chemicals and Reagents 
Fetal bovine serum (FBS) and Dulbecco's Modified 
Eagle's Medium (DMEM) were purchased from Gibco, USA. 
Antibiotics solution (penicillin-streptomycin) was procured 
from Himedia, India, while 3-(4, 5-diamethyl-2-thiazolyl)-2, 
5-diphenyl-2H-tetrazolium) (MTT), Direct Red 80 and 
ethylene diamine tetra acetic acid (EDTA) were purchased 
from Sigma, USA. L-ascorbic acid was purchased from Alfa-
Aesar, while kojic acid was purchased from Sigma, USA. 
Epidermal growth factor (EGF) was procured from Gibco, 
ThermoFisher, USA. ELISA kits were procured from 
CUSABIO and CusAb Co. Pvt. Ltd., USA. Zinc chloride was 
purchased from TCI, Japan, sodium selenate from Alfa-
Aesar, USA, while sodium molybdate from Sigma-Aldrich, 
USA. Tetrahydrocurcumin and Centella asiatica extract were 
procured from Novel Nutrients Pvt. Ltd., India and Sanat 
Products Ltd., India, respectively. All the other chemicals 
used in this experiment were analytical grade procured from 
India.  
2.2. Cell Culture 
The human foreskin fibroblast-1 (HFF-1) cells were 
procured from American Type Culture Collection (ATCC), 
USA. B16-F10 (mouse melanoma) cells were procured from 
National Centre for Cell Science (NCCS), Pune. HFF-1 and 
B16-F10 cell lines were maintained in the growth medium 
DMEM supplemented with 15% FBS, with added antibiotics 
penicillin (100 U/mL) and streptomycin (100 µg/mL). The 
growth condition of cell lines were 37°C, 5% CO2, and 95% 
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humidity. L-ascorbic acid (for ECM, UV-B protection, and 
wound healing assay) in concentrations ranges from 10 µM 
to 1000 µM, while kojic acid (for melanin synthesis) 
concentrations ranges from 1 mM to 10 mM, FBS (0.5%) 
was used in cell proliferation (BrdU) assay, while EGF 10 
µM was used in MTT assay.  
2.3. Experimental Design 
The experimental groups consisted of cells in normal 
control, vehicle control group (0.05% DMSO), positive 
control group (L-ascorbic acid/kojic acid/EGF/FBS) and test 
groups. The test groups included the combination of Biofield 
Energy Treated and untreated test formulation/DMEM. It 
consisted of four major treatment groups on specified cells 
with UT-DMEM + UT-Test formulation, UT-DMEM + BT-
Test formulation, BT-DMEM + UT-Test formulation, and 
BT-DMEM + BT-Test formulation. 
2.4. Consciousness Energy Healing Treatment Strategies 
The test formulation and DMEM were distributed into two 
parts. One of each part was defined as untreated samples, 
while the other parts of each were selected as the treated 
samples. Both the samples were kept under standard 
laboratory conditions at the research laboratory of Dabur 
Research Foundation, near New Delhi, India. The treated 
samples were subjected to the Consciousness Energy Healing 
(The Trivedi Effect
®
) Treatment by Shirley Theresa 
Holmlund remotely for 5 minutes from Canada. The Biofield 
Energy Healer, Shirley Theresa Holmlund, never visited the 
laboratory in person, nor had any contact with the test 
samples. In similar way, the control samples were subjected 
to “sham” healer under the same laboratory conditions for 5 
minutes. The sham healer was not aware of the Biofield 
Energy Treatment. After that, the Biofield Energy Treated 
and untreated samples were kept in similar sealed conditions 
and used for this experiment. 
2.5. Determination of Non-cytotoxic Concentration  
The cell viability was performed by MTT assay in three 
cell lines such as HFF-1 (human fibroblast), HaCaT (human 
keratinocytes), and B16-F10 (mouse melanoma). The cells 
were counted and plated in 96 well plates at the density 
corresponding to 5 × 10
3
 to 10 × 10
3
 cells/well/180 µL of cell 
growth medium. The above cells were incubated overnight 
under growth conditions and allowed the cell recovery and 
exponential growth, which were subjected to serum stripping 
or starvation. The cells were treated with the test formulation 
and DMEM/positive controls. The untreated cells served as 
baseline control. The cells in the above plate(s) were 
incubated for a time point ranging from 24 to 72 hours in 
CO2 incubator at 37°C, 5% CO2 and 95% humidity. 
Following incubation, the plates were taken out and 20 µL of 
5 mg/mL of MTT solution was added to all the wells 
followed by additional incubation for 3 hours at 37°C. The 
supernatant was aspirated and 150 µL of DMSO was added 
to each well to dissolve formazan crystals. The absorbance of 
each well was read at 540 nm using Synergy HT micro plate 
reader, BioTek, USA. The concentrations exhibiting % 
cytotoxicity of < 30 % was considered as non-cytotoxic [36, 
37]. The percentage of cell viability was calculated using 
formula (1): 
% Cell viability = (X*100)/R)                       (1) 
Where, X represents the absorbance of the cells 
corresponding to positive control and test groups and R 
represents the absorbance of the cells corresponding to the 
baseline (control cells) group. 
2.6. Effect of the Test Item on Fibroblast Proliferation by  
5-Bromo-2'-Deoxyuridine (BrdU) Method 
HFF-1 cells were counted using hemocytometer and plated 
in 96 well plate at the density corresponding to 1 × 10
3
 to 5 × 
10
3
 cells/well in DMEM supplemented with 15% FBS. The 
cells/plates were incubated overnight under growth 
conditions so as to allow cell recovery and exponential 
growth. Following overnight incubation, the above cells were 
subjected to serum starvation. Following serum starvation, 
the cells were treated with non-cytotoxic concentrations of 
the test substance and positive control. Following 24 to 72 
hours of incubation with the test substance and positive 
control, the plates were taken out and 5-bromo-2'-
deoxyuridine (BrdU) estimation using cell proliferation 
ELISA, BrdU estimation kit (ROCHE – 11647229001) as per 
manufacturer’s instructions. 
2.7. Estimation of Extracellular Matrix (ECM) 
Synthesis of extracellular matrices component (i.e. 
collagen, elastin, and hyaluronic acid) in HFF-1 cells was 
estimated for determining the potential of the Biofield 
Energy Treated test formulation and DMEM to improve skin 
strength, elasticity and hydration level. HFF-1 cells were 
counted using hemocytometer and plated in 48 well plate at 
the density corresponding to 10 × 10
3
 cells/well in DMEM 
supplemented with 15% FBS. The cells were incubated 
overnight under specified growth conditions followed by 
cells to serum stripping. Further, the cells were treated with 
different groups viz. vehicle control (DMSO-0.05%), positive 
control (ascorbic acid, at 10 µM concentration), and the test 
samples at various concentrations. Further, after 72 hours of 
incubation with the test items and positive control, the 
supernatants from all the cell plates were taken out and 
collected in pre-labeled centrifuge tubes for the estimation of 
elastin and hyaluronic acid levels. However, the 
corresponding cell layers were processed for the estimation 
of collagen level using Direct Sirius red dye binding assay 
[38]. Elastin and hyaluronic acid were estimated using 
ELISA kits from Cusabio Biotech Co. Ltd., Human Elastin 
ELN Elisa kit 96T and Human Hyaluronic Acid, Elisa kit 
96T, respectively [39].  
2.8. Estimation of Melanin Synthesis 
B16-F10 cells were used for the estimation of melanin 
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synthesis. The cells were counted using hemocytometer and 
plated in 90 mm culture dish at the density corresponding to 
2 × 10
6
 per 6 mL in culture plates. Further, the cells were 
incubated overnight under specified growth conditions and 
allowed for cell recovery and exponential growth. After 
incubation, the cells were treated with α-melanocyte-
stimulating hormone (α-MSH) for a time point ranging from 
4 to 24 hours for the stimulation of intracellular melanin 
synthesis. Further, the cells were incubated with α-MSH. 
After incubation, intracellular melanin was extracted in 
NaOH and the absorbance was recorded at 405 nm. The level 
of melanin was extrapolated using standard curve obtained 
from purified melanin [40].  
2.9. Anti-wrinkle Effects of the Test Formulation on HFF-1 
Cells Against UV-B Induced Stress 
UV-B induced stress was evaluated in HFF-1 cells and cell 
viability was estimated in the presence of the test samples. 
The cells were counted using hemocytometer and plated in 
96 well plate at the density corresponding to 5 × 10
3
 to 10 × 
10
3
 cells/well in DMEM supplemented with 15% FBS 
cells/plates, which were incubated overnight under growth 
conditions to allow cell recovery and exponential growth. 
The cells were treated with non-cytotoxic concentrations of 
the test samples for 2 to 24 hours. After treatment with the 
test samples, the cells were subjected to the lethal dose of 
UV-B irradiation (200 mJ/cm
2
) that can lead to 
approximately 50% cytotoxicity (302 nm, CL-1000 M, UVP, 
USA) [41]. The percent cell viability was assessed using 
formula (2): 
% Cell viability = (X*100)/R                          (2) 
Where, X represents the absorbance of cells corresponding 
to positive control and test groups, and R represents the 
absorbance of cells corresponding to the baseline (control 
cells) group.  
2.10. Wound Healing Activity by Scratch Assay  
HFF-1 and HaCaT cells were counted using 
hemocytometer and plated in 12 well plates at the densities 
0.08 × 10
6
/well/mL of cell growth medium. The cells/plates 
were incubated overnight under growth conditions and 
allowed cell recovery and exponential growth. After 
overnight incubation, the cells were subjected to the serum 
starvation in DMEM for 24 hours. Mechanical scratches that 
represent a wound was created in the near confluent 
monolayer of cells by gently scraping with a sterile 200 µL 
micropipette tip. The cells were then rinsed with the serum 
free DMEM and treated with the test formulation. The 
scratched area was then monitored for a time period ranging 
from 0 to 48 hours for closure of wound area. The 
photomicrographs (×10) were done at the selected time point 
(at 16 hours) of migrated cells using a digital camera. It 
represented fibroblast distance covered and subsequent 
scratch closure [42].  
2.11. Statistical Analysis 
Each experiment was carried out in three independent 
assays and was represented as mean values with standard 
error of mean (SEM). For multiple group comparison, one-
way analysis of variance (ANOVA) was used followed by 
post-hoc analysis by Dunnett’s test. Statistically significant 
values were set at the level of p≤0.05. 
3. Results and Discussion 
3.1. Assessment of Cell Viability by MTT Assay  
The percentage of viable cells was evaluated using MTT 
assay in three different cell lines (HFF-1, HaCaT, and B16-
F10) is shown in Figure 1A to 1C. The result of cell viability 
in the HFF-1 cells showed approximately >70% viable cells 
in the tested concentrations ranges from 0.625 to 10 µg/mL 
(Figure 1A). Hence, these concentrations were used for 
further estimation of extracellular matrix (ECM) synthesis in 
HFF-1 cells such as collagen, elastin, and hyaluronic acid. 
The results of percentage cell viability in HaCaT cells data 
revealed that the tested concentrations exhibited >95% cell 
viability. Hence, the concentration (5 to 40 µg/mL) was used 
further for the estimation of wound healing activity by 
scratch assay (Figure 1B). The percentage of viable cells in 
the B16-F10 cells data exhibited that the test concentrations 
were non-cytotoxic (i.e. percentage cell viability 
value >70%). Hence, the tested concentrations were used 
further for the measurement of melanin level at the 
concentrations ranging from 10 to 40 µg/mL (Figure 1C). 
 
Figure 1. Effect of the test formulation on cell viability in different cells at various concentrations A. HFF-1 cells after 72 hours of treatment. B. HaCaT cells 
after 48 hours of treatment. C. B16-F10 cells after 48 hours of treatment. LA: L-Ascorbic acid; EGF: Epidermal growth factor. 
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3.2. BrdU Assay for Cell Proliferation 
The percentage of cell proliferation was analysed using 
BrdU assay and the data are shown in Figure 2. The percent 
cell proliferation in the vehicle control (VC) and positive 
control groups (FBS-0.5 µg/mL) showed 117.2% and 
250.4%, respectively. At 8.75 µg/mL, the percent cell 
proliferation was increased by 343.57%, 100.29%, and 
132.6% in the UT-DMEM + BT-Test formulation, BT-
DMEM + UT-Test formulation, and BT-DMEM + BT-Test 
formulation groups, respectively compared to the UT-
DMEM + UT-Test formulation group. Further, the percent 
cell proliferation was significantly enhanced by 134.71%, 
369.90%, and 126.21% in the UT-DMEM + BT-Test 
formulation, BT-DMEM + UT-Test formulation, and BT-
DMEM + BT-Test formulation groups, respectively at 17.5 
µg/mL with respect to the UT-DMEM + UT-Test 
formulation group. The percentage of cell proliferation was 
elevated significantly by 119.57% and 216.29% in the UT-
DMEM + BT-Test formulation and BT-DMEM + UT-Test 
formulation groups, respectively at 35 µg/mL compared to 
the UT-DMEM + UT-Test formulation group. Cell 
proliferation plays an important role in cellular homoeostasis 
for proper growth, development and maintenance of an 
organism. The assay using bromodeoxyuridine (BrdU) 
mainly designed for the assessment of three objectives viz. 
for measuring the rate of DNA replication, analysis of 
metabolic activity and recognitions of cell surface antigen 
activity [43]. Overall, the percent cell proliferation in the 
Biofield Energy Treated Test formulation and DMEM was 
improved.  
 
Figure 2. Effect of the test formulation on cellular proliferation after 48 hours using BrdU assay. VC: Vehicle control; FBS: Fetal bovine serum (µg/mL); UT: 
Untreated; BT: Biofield Treated. 
3.3. Impact of the Test Formulation on Synthesis of 
Extracellular Matrix (ECM) Components in Human 
Foreskin Fibroblast (HFF-1) 
3.3.1. Collagen 
The effects of the test formulation and DMEM on the 
collagen level in HFF-1 cells is shown in Figure 3. The level of 
collagen in the vehicle control (VC) and positive control 
groups were 83.62 ± 1.42 and 129.42 ± 8.50 µg/mL, 
respectively. Collagen level was increased by 5.94% and 
10.84% in the UT-DMEM + BT-Test formulation and BT-
DMEM + BT-Test formulation groups, respectively at 0.625 
µg/mL compared to the UT-DMEM + UT-Test formulation 
group. Additionally, the collagen was increased by 3.68% and 
2.63% in the UT-DMEM + BT-Test formulation and BT-
DMEM + BT-Test formulation groups, respectively at 1.25 
µg/mL with respect to the UT-DMEM + UT-Test formulation 
group. Further, the synthesis of collagen was increased by 
6.81% in the UT-DMEM + BT-Test formulation group at 2.5 
µg/mL with respect to the UT-DMEM + UT-Test formulation 
group. Collagen is a crucial component responsible for unique 
physiological process of wound healing [44]. Several potential 
stimuli such as local tissue ischemia, bioburden, necrotic 
tissue, repeated trauma, etc. causes wounds in the 
inflammatory phase which contributes the chronic nature of 
the wound. In chronic wounds, there was an elevation of 
matrix metalloproteinases (MMPs) enzymes that degraded the 
both viable as well as non-viable collagen [45]. Ultimately, due 
to damage of collagen the repair process also delayed. 
Therefore, the control of collagen metabolism might be useful 
for a variety of therapeutic and cosmetic applications. Overall, 
the level of collagen synthesis was improved to some extent in 
the Biofield Energy Treated test formulation and DMEM, due 
to The Trivedi Effect
®
 - Biofield Energy Healing.
  
 
Figure 3. Effect of the test formulation on human foreskin fibroblast cells 
(HFF-1) for extracellular matrix component, collagen.  
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3.3.2. Elastin 
The effects of the test formulation and DMEM on the elastin 
level in the human foreskin fibroblast cells (HFF-1) is 
presented in Figure 4. The level of elastin was found as 6.06 ± 
0.00 and 7.27 ± 0.15 pg/mL in the vehicle control (VC) and 
positive control, respectively. The level of elastin was 
significantly (p≤0.001) increased by 15.95%, 58.31%, and 
47.18% at 2.5 µg/mL in the UT-DMEM + BT-Test 
formulation, BT-DMEM + UT-Test formulation, and BT-
DMEM + BT-Test formulation groups, respectively compared 
to the UT-DMEM + UT-Test formulation group. Moreover, at 
5 µg/mL the level of elastin was significantly (p≤0.001) 
elevated by 44.15%, 20.83%, and 71.39% in the UT-DMEM + 
BT-Test formulation, BT-DMEM + UT-Test formulation, and 
BT-DMEM + BT-Test formulation groups, respectively 
compared to the UT-DMEM + UT-Test formulation group. 
Further, at 10 µg/mL the expression of elastin was also 
significantly (p≤0.001) increased by 119.73%, 76.98%, and 
181.73% in the UT-DMEM + BT-Test formulation, BT-
DMEM + UT-Test formulation, and BT-DMEM + BT-Test 
formulation groups, respectively compared to the UT-DMEM 
+ UT-Test formulation group. Elastin is responsible to 
maintain the mechanical and cell interactive properties to the 
skin. It also imparts recoil and resistance properties and 
induces a wide-range of cellular activities such as cell 
migration and proliferation, matrix synthesis, and protease 
production [46]. Due to these inherent properties of elastin, it’s 
a desirable inclusion to wound healing process. Cutaneous 
ageing is the result of two biological processes which may 
occur simultaneously as termed as intrinsic ageing and 
extrinsic ageing. The intrinsic aged skin is due to dryness and 
lack of elastin as found in youthful skin [47]. Overall, the level 
of elastin synthesis was improved significantly in the Biofield 
Energy Treated test formulation and DMEM, due to The 
Trivedi Effect
®
 - Consciousness Energy Healing.
 
 
 
***p≤0.001 vs UT-DMEM + UT-Test formulation using one-way ANOVA (post-hoc Dunnett’s test). 
Figure 4. Effect of the test formulation on elastin in human foreskin fibroblast cells (HFF-1).  
3.3.3. Hyaluronic Acid (HA) 
The effects of the test formulation with DMEM on HA 
level in human foreskin fibroblast cells (HFF-1) is 
represented in Figure 5. The results of HA synthesis in the 
presence of ascorbic acid (10 µM), showed significantly 
increased in HA content by 56.27% compared with the 
vehicle control (VC) group (7.82 ± 0.01 ng/mL). The level of 
HA was significantly increased by 15.13% and 68.56% in the 
BT-DMEM + UT-Test formulation and BT-DMEM + BT-
Test formulation groups, respectively at 0.625 µg/mL 
compared to the UT-DMEM + UT-Test formulation group. 
Further, at 1.25 µg/mL the HA level was significantly 
increased by 5.18% and 56.39% in the BT-DMEM + UT-
Test formulation and BT-DMEM + BT-Test formulation 
groups, respectively compared to the UT-DMEM + UT-Test 
formulation group. Additionally, the level of HA was 
significantly increased by 31.40% in the BT-DMEM + BT-
Test formulation group with respect to the UT-DMEM + UT-
Test formulation group at 2.5 µg/mL. The overall data 
suggested that the Biofield Energy based test formulation and 
DMEM have the significant capacity to increase the extra-
cellular skin component, hyaluronic acid.  
 
Figure 5. Effect of the test formulation on hyaluronic acid (HA) in human foreskin fibroblast cells (HFF-1).  
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3.4. Effect of the Test Formulation on Skin Depigmentation  
The effect of the test formulation and DMEM on alpha-
MSH stimulated melanin synthesis in B16-F10 cells is shown 
in Figure 6. The level of melanin was significantly decreased 
by 63.49% in the kojic acid (KA) group (9.09 ± 3.03 µg/mL) 
compared to the α-MSH group (24.61 ± 0.61 µg/mL). The 
cellular content of melanin was reduced by 3.49% and 7.05% 
in the UT-DMEM + BT-Test formulation and BT-DMEM + 
BT-Test formulation groups, respectively at 0.013 µg/mL 
compared to the UT-DMEM + UT-Test formulation group. 
Besides, the level of melanin synthesis was significantly 
inhibited by 17.06%, 6.94%, and 13.07% in the UT-DMEM 
+ BT-Test formulation, BT-DMEM + UT-Test formulation, 
and BT-DMEM + BT-Test formulation groups, respectively 
at 0.063 µg/mL compared to the UT-DMEM + UT-Test 
formulation group. Additionally, the melanin synthesis was 
suppressed by 7.98% and 14.95% in the UT-DMEM + BT-
Test formulation and BT-DMEM + UT-Test formulation 
groups, respectively compared to the UT-DMEM + UT-Test 
formulation group. Thus, based on this result it can be 
concluded that the Biofield Energy Treated test formulation 
and DMEM inhibits the melanin production in the B16-F10 
melanoma cells. This improvement could be beneficial for 
the development of a cosmeceuticals for hyperpigmentation 
for different types of skin conditions.  
 
KA: Kojic acid (mM); α-MSH: Alpha-melanocyte-stimulating hormone. 
Figure 6. Effect of the test formulation and DMEM on alpha-MSH stimulated melanin level in B16-F10 cells.  
3.5. Anti-wrinkle Effect of the Test Formulation on HFF-1 
Cells Against UV-B Induced Stress 
The effect of the Biofield Energy Treated test formulation 
with DMEM against UV-B challenge is represented in Figure 
7. The cell viability was measured using hemocytometer. The 
cells were subjected to a lethal dose of UV-B irradiation (200 
mJ/cm
2
) and found 39.56% cell viability. The cell viability in 
the normal control (NC) and vehicle control (VC) groups was 
100% and 27.78%, respectively. The percent cell viability 
was increased by 55.41% in the L-ascorbic acid group 
compared to the VC. The percent cell viability was increased 
by 3.08% and 4.06% in the BT-DMEM + BT-Test 
formulation group at 0.625 µg/mL and 1.25 µg/mL, 
respectively compared with the UT-DMEM + UT-Test 
formulation group. Wrinkles occurs due to various factors 
like aging, genetics, and environmental factors such as 
ultraviolet radiation, smoking and also due to deficiency of 
estrogen [48, 49]. Among these, aging is one of the most 
crucial factors responsible for skin wrinkles. In humans, due 
to aging the skin becomes thin, decrease elasticity and the 
content of glycosamino glycans, collagen, etc. [50, 51]. The 
data suggests that the both Biofield Energy Treated test 
formulation and DMEM could be significantly used for anti-
wrinkling activity.  
 
NC: Normal control. 
Figure 7. Percentage restoration of cell viability in HFF-1 cells after 20 
hours pretreatment of the test formulation before UV-B challenge.  
3.6. Wound Healing Activity by Scratch Assay 
The wound healing activity using scratch assay of the test 
formulation and DMEM was evaluated to measure cell 
migration in HFF-1 and HaCaT cells. The representative 
photomicrographs are depicted in Figure 8. The cell coverage 
area was increased by 3% in the UT-DMEM + BT-Test 
formulation group, respectively at 0.625 µg/mL in HFF-1 
cells compared to the UT-DMEM + UT-Test formulation 
group. Further, the cell coverage area was increased by 8% 
and 5% in the BT-DMEM + UT-Test formulation and BT-
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DMEM + BT-Test formulation groups, respectively at 5 
µg/mL in HFF-1 cells compared to the UT-DMEM + UT-
Test formulation group (Figure 8A). The cell coverage area 
was increased by 3% in the UT-DMEM + BT-Test 
formulation and BT-DMEM + BT-Test formulation groups, 
respectively at 0.625 µg/mL in HaCaT cells compared to the 
UT-DMEM + UT-Test formulation group. Moreover, the cell 
coverage area was increased by 2% in the UT-DMEM + BT-
Test formulation and BT-DMEM + BT-Test formulation 
groups, respectively at 5 µg/mL in HaCaT cells compared to 
the UT-DMEM + UT-Test formulation group (Figure 8B). 
The scratch assay for screening the wound healing activity is 
a well-established method that measured the cell migration, 
cell-matrix and cell-to-cell interactions during wound healing 
process [52]. The results showed significant wound closure 
activity in HFF-1 cells compared to the untreated group.  
 
Figure 8. Effect of the test formulation and DMEM on wound healing 
activity after 16 hours of treatment. Representative photomicrographs (×10) 
of wound closure and cell migration are shown in (A). HFF-1 and (B). 
HaCaT cells.  
4. Conclusions 
The cell viability by MTT assay exhibited more than 70% 
cells were viable in all the tested concentrations. The percent 
cell proliferation using BrdU assay at 8.75 µg/mL was 
significantly increased by 343.57%, 100.29%, and 132.6% in 
the UT-DMEM + BT-Test formulation, BT-DMEM + UT-
Test formulation, and BT-DMEM + BT-Test formulation 
groups, respectively compared to the UT-DMEM + UT-Test 
formulation group. The level of collagen was increased by 
5.94% and 10.84% in the UT-DMEM + BT-Test formulation 
and BT-DMEM + BT-Test formulation groups, respectively 
at 0.625 µg/mL with respect to the UT-DMEM + UT-Test 
formulation group. The level of elastin was significantly 
(p≤0.001) increased by 15.95%, 58.31%, and 47.18% at 2.5 
µg/mL in the UT-DMEM + BT-Test formulation, BT-
DMEM + UT-Test formulation, and BT-DMEM + BT-Test 
formulation groups, respectively compared to the UT-
DMEM + UT-Test formulation group. Moreover, elastin 
level at 10 µg/mL was significantly (p≤0.001) increased by 
119.73%, 76.98%, and 181.73% in the UT-DMEM + BT-
Test formulation, BT-DMEM + UT-Test formulation, and 
BT-DMEM + BT-Test formulation groups, respectively 
compared to the UT-DMEM + UT-Test formulation group. 
Hyaluronic acid was increased by 15.13% and 68.56% at 
0.625 µg/mL in the BT-DMEM + UT-Test formulation and 
BT-DMEM + BT-Test formulation groups, respectively 
compared to the UT-DMEM + UT-Test formulation group. 
However, it was also increased by 5.18% and 56.39% in the 
BT-DMEM + UT-Test formulation and BT-DMEM + BT-
Test formulation groups, respectively at 1.25 µg/mL 
compared to the UT-DMEM + UT-Test formulation group. 
Melanin level was reduced by 17.06%, 6.94%, and 13.07% in 
the UT-DMEM + BT-Test formulation, BT-DMEM + UT-
Test formulation, and BT-DMEM + BT-Test formulation 
groups, respectively at 0.063 µg/mL with respect to the UT-
DMEM +UT-Test formulation group. Protection with respect 
to UV-B, showed that the percent cell viability was altered 
minimally in the different test concentrations. Wound healing 
results showed significant effects on wound closure and cell 
migration in the test formulation and DMEM groups in HFF-
1 cells compared to the untreated group. Overall, the Biofield 
Energy Treated test formulation (The Trivedi Effect
®
) and 
DMEM have shown significant protective effects on various 
skin health parameters such as skin whitening, aging, 
wrinkling, and wound healing. Therefore, the Biofield 
Energy Healing based test formulation could be suitable for 
the development of herbal cosmetics, and it would be useful 
for the management of wounds and various skin related 
disorders viz. cellulitis, abscess, syringoma, pimple, 
impetigo, scabies, photosensitivity, urticaria, hives, warts, 
acne, abscess, callus, skin aging, wrinkles and/or change in 
skin color, chickenpox, eczema, rosacea, seborrheic 
dermatitis, athlete's foot, psoriasis, contact dermatitis, cutis 
rhomboidalis nuchae, erythema, etc.  
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